Targonski P V, Frank W, Stuhldreher D, Guinan P D
Division of Epidemiology-Biostatistics Program, University of Illinois School of Public Health, Chicago 60612.
J Urol. 1994 Nov;152(5 Pt 1):1389-92. doi: 10.1016/s0022-5347(17)32427-8.
Results in the literature are inconsistent regarding the value of tumor size in predicting survival from renal cell carcinoma, and its use as a staging variable in the current tumors, nodes and metastases system has been questioned. In this study tumor size had no prognostic significance in Kaplan-Meier or Cox regression models examining survival differences between 93 patients with stage T1N0M0 and T2N0M0 renal cell carcinoma dichotomized by tumor size cutoffs at 2.5, 5, 7.5 or 10 cm. In multivariate Cox regression models for 122 patients with stage T1NallMall or T2MallMall renal cell carcinoma, metastatic disease was the strongest predictor of survival, and patients with smaller tumors had significantly longer survival than those with larger tumors at all cutoffs except 2.5 cm., for which differences were insignificant. A 5 cm. cutoff maximized the value of tumor size in predicting survival. If tumor size is to remain the variable by which tumors, nodes and metastases stages T1 and T2 disease are differentiated, a 5 cm. cutoff should replace the current 2.5 cm. definition.
关于肿瘤大小在预测肾细胞癌生存率方面的价值,文献中的结果并不一致,并且其在当前的肿瘤、淋巴结和转移(TNM)系统中作为分期变量的用途也受到了质疑。在本研究中,在通过2.5、5、7.5或10厘米的肿瘤大小临界值将93例T1N0M0和T2N0M0期肾细胞癌患者分为两组,以检验生存差异的Kaplan-Meier或Cox回归模型中,肿瘤大小没有预后意义。在针对122例T1NallMall或T2MallMall期肾细胞癌患者的多变量Cox回归模型中,转移性疾病是生存的最强预测因素,除2.5厘米外(该临界值下差异不显著),在所有临界值下,肿瘤较小的患者比肿瘤较大的患者生存时间显著更长。5厘米的临界值在预测生存方面使肿瘤大小的价值最大化。如果肿瘤大小要继续作为区分肿瘤、淋巴结和转移分期中T1和T2期疾病的变量,5厘米的临界值应取代当前的2.5厘米定义。